WS #16961

The market narrative has shifted from broad-based AI de-risking to a bifurcated landscape where geopolitical escalation and specific corporate catalysts drive divergent sector performance. The prevailing narrative of a Democratic sweep triggering a tech correction is being tested by mixed election results, including a Republican hold in New York, while the Middle East tension theme remains firmly in escalation mode, supporting defense and energy beneficiaries despite broader market weakness. This divergence suggests that while macro liquidity concerns persist, idiosyncratic political and geopolitical risks are now the primary drivers of alpha and beta. In the technology sector, the synchronized semiconductor selloff continues, but emerging signals point to a potential stabilization as hyperscalers like Microsoft and Meta are closely watched for capex guidance. Meanwhile, the energy sector is seeing renewed strength due to the escalation in Middle East tensions, which threatens supply routes and supports higher oil prices, benefiting integrated majors and refiners while pressuring airlines. In biotech, Moderna's upcoming earnings report is a critical focal point, with the market debating valuation amidst cancer vaccine results, creating a high-impact binary event for the healthcare sector.